Promising New PD Fluid
In a Phase 2 study, PD-protec® from Zytoprotec in Vienna, Austria, reduced the risk of peritonitis and of membrane failure. The new fluid was well-tolerated, with no adverse events. Once on the market, this fluid could improve PD outcomes and allow more people to stay longer on the therapy.
Read the full article » | Posted 07-14-2017
Related Articles
- New Measure of Home Dialysis Dropout Posted 01-16-2024
- Check out the NextKidney Neokidney HD Machine Posted 11-15-2023
- New Redsense Clamp Add-on Will Stop the Blood Pump! Posted 10-13-2023
- AWAK Technologies Raised Another $20 million for Shoulder Bag Sized Wearable PD Posted 10-13-2023